DMARD Taper-to-Discontinuation Approach Increases Flare Risk

Source link :

Patients with rheumatoid arthritis (RA) in remission who tapered and then fully stopped either conventional synthetic disease-modifying antirheumatic drug (csDMARD) or tumor necrosis factor (TNF) inhibitor therapy experienced more disease flares than those who received stable dose treatment in an open-label, randomized trial. In the 3-year trial, called ARCTIC REWIND, 80% of patients taking stable […]

Author : News Health

Publish date : 2024-04-15 06:38:43

Copyright for syndicated content belongs to the linked Source.